Asteria Zitrou

Title: Asteria Zitrou: Innovator in Pharmaceutical Chemistry

Introduction

Asteria Zitrou is a prominent inventor based in Salonika, Greece. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. Her innovative work has led to the creation of a valuable patent that enhances the preparation of important pharmaceutical intermediates.

Latest Patents

Asteria Zitrou holds a patent for a process titled "Process for the preparation of a propenal intermediate and derivatives thereof." This invention provides an improved method for synthesizing (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methyl methanesulfonamide. This compound is a crucial intermediate in the production of Rosuvastatin, a widely used medication for lowering cholesterol.

Career Highlights

Asteria Zitrou is associated with Pharmathen S.A., a leading pharmaceutical company known for its commitment to innovation and quality in drug development. Her work at Pharmathen has positioned her as a key player in the pharmaceutical industry, contributing to advancements in drug formulation and synthesis.

Collaborations

Throughout her career, Asteria has collaborated with notable colleagues, including Theoharis V Koftis and Thanos Andreou. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Asteria Zitrou's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. Her patent and work at Pharmathen highlight her role as a leading inventor in the industry. Asteria's dedication to improving pharmaceutical processes continues to influence the field positively.